The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Beam Therapeutics Inc (NASDAQ: BEAM) closed at $24.12 up 0.29% from its previous closing price of $24.05. In other words, the price has increased by $0.29 from its previous closing price. On the day, 1.27 million shares were traded. BEAM stock price reached its highest trading level at $25.05 during the session, while it also had its lowest trading level at $23.715.
Ratios:
For a deeper understanding of Beam Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.69 and its Current Ratio is at 5.69. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on November 06, 2024, Upgraded its rating to Outperform and sets its target price to $39 from $27 previously.
On July 23, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $80.H.C. Wainwright initiated its Buy rating on July 23, 2024, with a $80 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 06 ’24 when Ciaramella Giuseppe sold 51,110 shares for $26.36 per share. The transaction valued at 1,347,050 led to the insider holds 109,150 shares of the business.
Ciaramella Giuseppe sold 51,110 shares of BEAM for $1,342,752 on Oct 14 ’24. The President now owns 160,260 shares after completing the transaction at $26.27 per share. On Oct 14 ’24, another insider, Giuseppe Ciaramella, who serves as the Officer of the company, bought 102,220 shares for $24.65 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BEAM now has a Market Capitalization of 1997271168 and an Enterprise Value of 1150501888. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.22 while its Price-to-Book (P/B) ratio in mrq is 2.52. Its current Enterprise Value per Revenue stands at 3.291 whereas that against EBITDA is -7.154.
Stock Price History:
Over the past 52 weeks, BEAM has reached a high of $49.50, while it has fallen to a 52-week low of $20.84. The 50-Day Moving Average of the stock is -1.62%, while the 200-Day Moving Average is calculated to be -10.01%.
Shares Statistics:
For the past three months, BEAM has traded an average of 935.34K shares per day and 1535450 over the past ten days. A total of 81.63M shares are outstanding, with a floating share count of 72.66M. Insiders hold about 12.25% of the company’s shares, while institutions hold 81.95% stake in the company. Shares short for BEAM as of 1730332800 were 12314053 with a Short Ratio of 13.17, compared to 1727654400 on 11356434. Therefore, it implies a Short% of Shares Outstanding of 12314053 and a Short% of Float of 19.450001.
